Nicholas Cauwenberghs, PhD

Cardiovascular Epidemiologist at Leuven University @KU_Leuven

[Department of Cardiovascular Sciences - KU Leuven @Cardio_KULeuven]

Join us at the DMI Meeting on 6-7 feb 2024 (in English)!
More information and registration: https://t.co/7f1Q8Sw41u

https://t.co/Ux24G9W4OT

[De VanHarte studie @VanHarteStudie]

Ready, set, go!

🫀 VanHarte is officieel gestart! De komende maanden onderzoeken we hoe meer mensen kunnen leren testen op risicofactoren voor hart- en vaatziekten.

Leer je graag testen of laat je je graag preventief onderzoeken? Laat het ons weten https://t.co/cBvRVRCByw!

[Elizabeth Jones @JonesLab_KUL]

PhD position in my lab available. Please pass it on to anyone you know. It will be cosupervised with Stephane Heymans. And part of the HFpEF-DIVA consortium with @Ebbabrak

https://t.co/c8AnFIPnx8

[Nicholas Cauwenberghs, PhD @CauwNi]

🫀 Hart- en vaatziekten voorkomen, dat doen we samen!
🔍 Ontdek in de onderstaande video hoe ook jij binnenkort mee kan bouwen aan het hartonderzoek van de toekomst.

Met dank aan @impetus4cs en @Cardio_KULeuven

[SciMingo @SciMingo]

Laat jij binnenkort je #hart nakijken door #vrijwilligers in de #supermarkt?

Nicholas Cauwenberghs (@cauwni) @KU_Leuven @med_fac werkt aan een gebruiksvriendelijke kit om dat mogelijk te maken.

Bekijk de video🎥 https://t.co/cb5I7i3ly5

[Nicholas Cauwenberghs, PhD @CauwNi]

Off we go! Our citizen science initiative @KU_Leuven aims for cheap and accessible health screenings for all. Big thanks to @impetus4cs and @Cardio_KULeuven for the invaluable support.

[impetus4cs @impetus4cs]

We are excited to announce that the 2024 #IMPETUS4CS Accelerator has officially begun!

Check out the #citizenscience projects taking part and stay tuned to see what they achieve over the next seven months!

https://t.co/OrJvECPtOX

[impetus4cs @impetus4cs]

And with that, our 2-week #citizenscience BootCamp has ended!

It was great working with our next cohort of prospective projects and helping equip them for the next seven months of the #IMPETUS4CS accelerator programme!

Check-in with us next month, for our official launch!

[Verily Health @verilyhealth]

Researchers from Verily, @DukeHealth + @StanfordMed demonstrate the potential for use of Verily’s Study Watch to help identify patients at risk for #HeartFailure. The study, published in @JCardFail, shows there is more to walking than the number of steps. https://t.co/hYs1DZ2GG7

[Jan Verwerft @VerwerftJan]

💥Registration is open💥

👉 7th Exercise Echocardiography Symposium 🚴‍♀️

online 💻/ in person 🤝

📅 Saturday 23 MAR 2024

📌HFpEF, unexplained dyspnea
📌Valvular Heart Disease,
📌Adult Congenital Heart Disease
📌Athlete's heart

🔗 to register 👇
https://t.co/lebIRNufwm

[Atherosclerosis @ATHjournal]

Focused protein-based phenogrouping is able to identify individuals at high risk for future ASCVD and may complement current risk stratification strategies
🔗https://t.co/xK7nEIk4ny
@CauwNi @sitnarf @KuznetsovaPhD @society_eas

[Youri Bekhuis @YouriBekhuis]

🔊 The first PRIORITY publication is now available in @FrontCVMedicine!

In this paper, we describe the rationale and design of our multicenter prospective RCT in patients along the HFpEF continuum (stage A-C).

Link: https://t.co/M0WEqd0CKR
Short tweetorial: 👇
1/n

[Elizabeth Jones @JonesLab_KUL]

Looking for a post-doc? The project investigates at how pulsatility is encoded in endothelial cells. It will involve a sheep model of continous flow and single-cell/bioinformatic approaches.

https://t.co/C8RrB53wpJ

[LLEW RODERICK @roderick_cardio]

Recruiting!! Join us in beautiful Leuven for an exciting project on gene regulatory networks and cell-cell interactions in cardiac remodelling investigated by single cell multiomics. Faculteit Geneeskunde KU Leuven Faculty of Medic…https://t.co/En3yXT2Ont https://t.co/bsJXlKD1mI

[Jürgen Duchenne @DuchenneJurgen]

Spread the word! Open PhD position at @Cardio_KULeuven! 🎓 Are you an MD or (bio)medical scientist with an enthusiasm for cardiac imaging, running (large scale) clinical trials, and collaborating with international hospitals, apply < 31 July via https://t.co/KQTweOkZvo! @JUVoigt

[Nicholas Cauwenberghs, PhD @CauwNi]

@Cardio_KULeuven @KULeuvenPT @CVEPLeuven @verocornelissen @WernerBudts

[Nicholas Cauwenberghs, PhD @CauwNi]

Hot off the press: How results from cardiopulmonary exercise testing can be interpreted in an integrative way to predict cardiovascular events in at-risk patients. https://t.co/3jYY3nHKxY #mdpidiagnostics via @diagnostic_mdpi

[Nicholas Cauwenberghs, PhD @CauwNi]

@Cardio_KULeuven @KU_Leuven

[Nicholas Cauwenberghs, PhD @CauwNi]

Hot of the press: why it's important to consider HF risk factors and type of echocardiographic abnormality when staging heart failure | @StanfordMed @DukeMedSchool @Verily https://t.co/LYP8Nnsvmi

[Andreas Gevaert @AndreasGevaert]

In a primary prevention cohort, unsupervised clustering identified phenogroups at higher CVD risk based on proteome, incremental to SCORE2 risk estimation - @CauwNi Late Breaking science at #ESCPrev2023 @verocornelissen @camilledewilde @hansen_phd @LabBowen

[ESH Annual Meetings @ESH_Annual]

Curious to know what awaits you at #ESH2023? Take a look at the Preliminary Programme and register at the early bird fee by April 3!
👉 https://t.co/imacfOdloA

[František Sabovčik @sitnarf]

Full-time Professor position at KU Leuven, Belgium: “PROFESSOR IN ARTIFICIAL INTELLIGENCE IN CARDIOVASCULAR HEALTHCARE”. Interdisciplinary research focus on both theoretical AI methodologies and applications in (mobile) cardiovascular healthcare.
https://t.co/I3NPSrrsn0